INDIANAPOLIS -- Indianapolis-based drugmaker Eli Lilly and Co. is about to introduce a device designed to help diabetics make fewer mistakes with their insulin doses.

Lilly, which already produces the Humalog insulin product, is now set to offer the Humapen Memoir, which electronically records the time and amount of multiple doses.

The device, which resembles a pen, will be for diabetics who take Humalog.

"Patients will be able to look back at their last few doses, because it actually goes back to two to three days of insulin dosing," Lilly spokesman Scott MacGregor said. "We see this as a major advancement in the day-to-day management of diabetes."

The device will hit the market on Feb. 1.